Dr Marceline Akieh-Pirkanniemi Joins Omgenis as Research and Development Director

Omgenis is pleased to announce the appointment of Dr Marceline Akieh-Pirkanniemi as Director of Research and Development.

Dr Akieh-Pirkanniemi brings extensive experience in pharmaceutical research and controlled drug-delivery technologies. Her expertise will be instrumental as Omgenis advances its magnesium microparticle technology from its current development stage towards a clinically and commercially viable treatment for periodontitis and peri-implantitis. In her new role, she will lead Omgenis’s research and development activities, including product formulation, preclinical development, manufacturing and regulatory-related development. Her appointment further strengthens Omgenis’s internal capabilities and supports the company’s ambition to develop a differentiated treatment solution for the global periodontal care market.

‍